Adverum Biotechnologies (ADVM)
5.95
+0.15 +2.59%
NASDAQ
Jun 20, 15:01
Delayed 2m
USD
View All Key Stats
ADVM Key Stats
| Income Statement | |
| Revenue (TTM) | 1.603M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.21 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -57.25M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -7.96K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 370.52M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 176.22 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 1.506 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -13.20M |
| Return on Equity (TTM) | Upgrade |
View All ADVM News
ADVM News
-
WireHeadlineTime (ET)
-
SA Breaking News06/20 14:27
-
SA Breaking News06/11 14:05
-
Yahoo06/07 07:45
-
Yahoo06/04 09:00
-
Globe Newswire06/04 09:00
-
Globe Newswire06/04 07:55
-
SA Breaking News05/23 11:51
-
SA Breaking News05/18 08:57
-
Yahoo05/18 08:00
-
Globe Newswire05/17 20:15
View All Events
ADVM Events
| Date | Type | Description |
|---|---|---|
| 08/08/2018 | Earnings | Adverum Biotechnologies Inc Second Quarter Earnings Results in 2018 |
| 03/06/2018 | Earnings | Adverum Biotechnologies Inc Fourth Quarter Earnings Results in 2017 |
| 11/08/2017 | Earnings | Adverum Biotechnologies Inc Third Quarter Earnings Results in 2017 |
| 08/08/2017 | Earnings | Adverum Biotechnologies Inc Second Quarter Earnings Results in 2017 |
ADVM Fundamentals
Income Statement View Statement
ADVM Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ADVM One Page Reports
- One Page Report Download
ADVM Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 5.95 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.adverum.com
- Investor Relations URL: http://investors.avalanchebiotech.com/phoenix.zhtml?c=253634&p=irol-irhome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Aug. 08, 2018
- Last Earnings Release: Mar. 06, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye.
ADVM Excel Add-In Codes
- Name: =YCI("ADVM","name")
- Description: =YCI("ADVM","description")
- Sector: =YCI("ADVM","sector")
- Industry: =YCI("ADVM","industry")
- Est. Current Fiscal Year End: =YCI("ADVM","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ADVM Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ADVM Tweets Stocktwits
Advertisement
